466
Views
70
CrossRef citations to date
0
Altmetric
Reviews

Niosomes as a propitious carrier for topical drug delivery

, &
Pages 261-272 | Published online: 19 Dec 2012

Bibliography

  • Akhilesh D, Hazel G, Kamath JV. Proniosomes – a propitious provesicular drug carrier. Int J Pharm Pharm Sci Res 2011;1(3):98-103
  • Brown MB, Martin GP, Jones SA, Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 2006;13(3):175-87
  • Rubio L, Alonso C, López O, Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid. Int J Dermatol 2011;50(7):881-9
  • Dubey A, Prabhu P, Kamath J. Nano structured lipid carriers: a novel topical drug delivery system. Int J PharmTech Res 2012;4(2):705-14
  • Higaki K, Nakayama K, Suyama T, Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 2005;288(2):227-33
  • Ghafourian T, Zandasrar P, Hamishekar H, The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release 2004;99(1):113-25
  • Sathali AAH, Rajalakshmi G. Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride. Int J PharmTech Res 2010;2(3):2081-9
  • Khan A, Sharma PK, Visht S, Niosomes as colloidal drug delivery system: a review. J Chronother Drug Deliv 2011;2(1):15-21
  • Handjani-Vila RM, Ribier A, Rondot B, Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmet Sci 1979;1:303-14
  • Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 2009;17(9):671-89
  • Verma AK, Bindal M. A review on niosomes: an ultimate controlled and novel drug delivery carrier. Int J Nanoparticles 2012;5(1):73-87
  • Yeh D, Pavlostathis SG. Anaerobic biodegradability of Tween surfactants used as a carbon source for the microbial reductive dechlorination of hexachlorobenzene. Water Sci Technol 2005;52(1-2):343
  • Nasr M, Mansour S, Mortada ND, Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 2008;25(7):499-512
  • Jain CP, Vyas SP, Dixit VK. Niosomal system for delivery of rifampicin to lymphatics. Indian J Pharm Sci 2006;68:575-8
  • Raja Naresh RA, Pillai GK, Udupa N, Antiinflammatory activity of niosome encapsulated diclofenac sodium in arthitic rats. Indian J Pharmacol 1994;26:46-8
  • Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 2010;99(4):2049-60
  • Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs 1994;31(3):81-6
  • Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001;228(1):43-52
  • Abdelkader H, Wu Z, Al-Kassas R, Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm 2012;433(1-2):142-8
  • Lala S, Pramanick S, Mukhopadhyay S, Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. J Drug Target 2004;12(3):165-75
  • Baillie AJ, Coombs GH, Dolan TF, Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol 1986;38(7):502-5
  • Desai TR, Finlay WH. Nebulization of niosomal all-trans-retinoic acid: an inexpensive alternative to conventional liposomes. Int J Pharm 2002;241(2):311-17
  • Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 2008;357(1-2):189-98
  • Abdelkader H, Ismail S, Hussein A, Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models. Int J Pharm 2012;432(1-2):1-10
  • Pugeat M, Nicolas MH, Dechaud H, Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism. J Gynecol Obstet Biol Reprod (Paris) 1991;20(8):1057
  • Ruckmani K, Jayakar B, Ghosal SK. Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. Drug Dev Ind Pharm 2000;26(2):217-22
  • Shi B, Fang C, You MX, Influence of PEG chain length on in vitro drug release and in vivo pharmacokinetics of hydroxycamptothecin (HCPT) loaded PEG-PHDCA niosomes. Chinese Pharm J 2005;40(21):1643-6
  • Pardakhty A, Varshosaz J, Roulholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 2007;328:130-41
  • Firthouse PUM, Halith SM, Wahab SU, Formulation and evaluation of miconazole niosomes. Int J PharmTech Res 2011;3(2):1019-22
  • Hofland HEJ, van der Geest R, Bodde HE, Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm Res 1994;11(5):659-64
  • Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm 2000;206:110-22
  • Rahimpour Y, Hamishehkar H. Liposomes in cosmeceutics. Expert Opin Drug Deliv 2012;9(4):443-55
  • Kraemer K. Sunlight and skin cancer. Proc Natl Acad Sci USA 1997;94:11-14
  • Dahl E, Aberg M, Rausing A, Basal cell carcinoma. Cancer 1992;70:104-8
  • Ananthaswamy HN, Pierceall WE. Molecular mechanism of ultraviolet radiation carcinogenesis. Photochem Photobiol 1990;52:19-136
  • Gross K, Kircik L, Kricorian G. 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007;33:433-40
  • Morse LG, Kendrick C, Hooper D, Treatment of squamous cell carcinoma with intralesional 5-fluorouracil. Dermatol Surg 2003;29:1150-3
  • Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surface B Biointerfaces 2005;41:25-32
  • Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 2005;298:98-107
  • Paolino D, Cosco D, Muzzalupo R, Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm 2008;353(1):233-42
  • Alvi IA, Madan J, Kaushik D, Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs 2011;22(8):774-82
  • Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm 2002;231(1):21-32
  • Dubey V, Mishra D, Dutta T, Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123(2):148-54
  • Su YH, Fang JY. Drug delivery and formulations for the topical treatment of psoriasis. Expert Opin Drug Deliv 2008;5(2):235-49
  • Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 2012;9(4):429-41
  • Javadzadeh Y, Hamishehkar H. Enhancing percutaneous delivery of methotrexate using different types of surfactants. Colloids Surface B Biointerfaces 2011;82(2):422-6
  • Lakshmi PK, Devi GS, Bhaskaran S, Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol 2007;73(3):157
  • Draelos ZD. New channels for old cosmeceuticals: aquaporin modulation. J Cosmet Dermatol 2008;7(2):83
  • Lakshmi PK, Bhaskaran S. Phase II study of topical niosomal urea gel – an adjuvant in the treatment of psoriasis. Int J Pharm Sci Rev Res 2011;7(1):1-7
  • Choi CM, Berson DS. Cosmeceuticals. Semin Cutan Med Surg 2006;25:163-8
  • Bissett DL, Robinson LR, Raleigh PS, Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol 2007;6(1):20-6
  • Shatalebi MA, Mostafavi SA, Moghaddas A. Niosome as a drug carrier for topical delivery of N-acetyl glucosamine. Res Pharm Sci 2010;5(2):107
  • Junyaprasert VB, Singhsa P, Suksiriworapong J, Physicochemical properties and skin permeation of span 60/tween 60 niosomes of ellagic acid. Int J Pharm 2012;423(2):303-11
  • Garg BJ, Saraswat A, Bhatia A, Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol 2010;76(3):231-8
  • Nogueira LS, Zancanaro PC, Azambuja RD. Vitiligo and emotions. An Bras Dermatol 2009;84(1):41-5
  • Kingo K, Aunin E, Karelson M, Gene expression analysis of melanocortin system in vitiligo. J Dermatol Sci 2007;48(2):113-22
  • Zhang XJ, Chen JJ, Liu JB. The genetic concept of vitiligo. J Dermatol Sci 2005;39(3):137-46
  • Manosroi J, Khositsuntiwong N, Manosroi W, Enhancement of transdermal absorption, gene expression and stability of tyrosinase plasmid (pMEL34)-loaded elastic cationic niosomes: potential application in vitiligo treatment. J Pharm Sci 2010;99(8):3533-41
  • Manosroi A, Khositsuntiwong N, Götz F, Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles. J Liposome Res 2009;19(2):91-8
  • Mahor S, Rawat A, Dubey PK, Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm 2007;340(1-2):13-19
  • Tang D, Shi Z, David TC. Vaccination onto bare skin. Nature 1997;388(6644):729-30
  • Shi Z, Curiel DT, Tang D. DNA-based non-invasive vaccination onto the skin. Vaccine 1999;17(17):2136-41
  • Mishra D, Dubey V, Asthana A, Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 2006;24(22):4847-55
  • Fan H, Lin Q, Morrissey GR, Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 1999;17:870-2
  • Vyas SP, Singh RP, Jain S, Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm 2005;296(1-2):80-6
  • Glenn GM, Scharton-Kersten T, Vassell R, Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol 1998;161(7):3211-14
  • Glenn GM, Rao M, Matyas GR, Skin immunization made possible by cholera toxin. Nature 1998;391(6670):851-2
  • Maheshwari C, Pandey RS, Chaurasiya A, Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B. Int Immunopharmacol 2011;11(10):1516-22
  • Kaur K, Jain S, Sapra B, Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation. Curr Drug Deliv 2007;4(4):276-82
  • Goyal C, Ahuja M, Sharma SK. Preparation and evaluation of anti-inflammatory activity of gugulipid-loaded proniosomal gel. Acta Pol Pharm 2011;68(1):147-50
  • Shahiwala A, Misra A. Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 2002;5(3):220
  • Lingan MA, Sathali AAH, Kumar MRV, Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Sci Rev Chem Commun 2011;1(1):7-17
  • Weiner N. Targeted follicular delivery of macromolecules via liposomes. Int J Pharm 1998;162(1-2):29-38
  • Jung S, Otberg N, Thiede G, Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol 2006;126(8):1728-32
  • Ruksiriwanich W, Manosroi J, Abe M, 5 [alpha]-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid. J Supercrit Fluid 2011;59:61-71
  • Manosroi A, Ruksiriwanich W, Abe M, Transfollicular enhancement of gel containing cationic niosomes loaded with unsaturated fatty acids in rice (Oryza sativa) bran semi-purified fraction. Eur J Pharm Biopharm 2012;81(2):303-13
  • Manosroi J, Khositsuntiwong N, Manosroi A. Performance test of gel containing extracts from Thai Lanna medicinal plants entrapped in niosomes for hair loss treatment. J Thai Tradit Altern Med 2008;6(2):1
  • Javadzadeh Y, Shokri J, Hallaj-Nezhadi S, Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol 2010;15(6):619-25
  • Tabbakhian M, Tavakoli N, Jaafari MR, Enhancement of follicular delivery of finasteride by liposomes and niosomes: 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323(1-2):1-10
  • Messenger A, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004;150(2):186-94
  • Mura S, Pirot F, Manconi M, Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 2007;15(2):101-8
  • Balakrishnan P, Shanmugam S, Lee WS, Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 2009;377(1):1-8
  • Mali N, Darandale S, Vavia P. Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment. Drug Deliv Transl Res 2012;1-6. DOI: 10.1007/s13346-012-0083-1
  • Maibach HI, Choi MJ. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005;18:209-19
  • Vyas J, Vyas P, Raval D, Development of topical niosomal gel of benzoyl peroxide. ISRN Nanotechnol 2011;1-6. DOI: 10.5402/2011/503158
  • Kempf M, Theobald U, Fiedler HP. Economic improvement of the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol Lett 1999;21(8):663-7
  • Manosroi A, Wongtrakul P, Manosroi J, The entrapment of kojic oleate in bilayer vesicles. Int J Pharm 2005;298(1):13-25
  • Manosroi A, Khanrin P, Lohcharoenkal W, Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 2010;392(1):304-10
  • Ridolfi DM, Marcato PD, Justo GZ, Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces 2012;93:36-40
  • Manconi M, Sinico C, Valenti D, Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006;311(1-2):11-19
  • Manconi M, Valenti D, Sinico C, Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 2003;260(2):261-72
  • Kaur IP, Kapila M, Agrawal R. Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing. Ageing Res Rev 2007;6(4):271-88
  • Rozman B, Zvonar A, Falson F, Temperature-sensitive microemulsion gel: an effective topical delivery system for simultaneous delivery of vitamins C and E. AAPS PharmSciTech 2009;10(1):54-61
  • Manosroi A, Chutoprapat R, Sato Y, Antioxidant activities and skin hydration effects of rice bran bioactive compounds entrapped in niosomes. J Nanosci Nanotechnol 2011;11(3):2269-77
  • Manosroi A, Chutoprapat R, Abe M, Anti-aging efficacy of topical formulations containing niosomes entrapped with rice bran bioactive compounds. Pharm Biol 2012;50(2):208-24
  • Manosroi A, Jantrawut P, Akihisa T, In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharm Biol 2011;49(11):1190-203

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.